Viewing Study NCT01016093

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2026-06-10 @ 12:06 PM
Study NCT ID: NCT01016093
Status: UNKNOWN
Last Update Posted: 2011-07-26
First Post: 2009-11-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients
Sponsor: Tehran University of Medical Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Beta-Thalassemia View
None Bone Marrow Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Thalassemia View
None BMT View
None HSCT View